Original Research

A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation

Anand E, Berggren L, Deix C, Tóth Á, McDonnell DP

Neuropsychiatric Disease and Treatment 2015, 11:1349-1357

Published Date: 27 May 2015